Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
43.8M
-
Number of holders
-
171
-
Total 13F shares, excl. options
-
37M
-
Shares change
-
+1M
-
Total reported value, excl. options
-
$481M
-
Value change
-
-$21.8M
-
Put/Call ratio
-
3.07
-
Number of buys
-
108
-
Number of sells
-
-90
-
Price
-
$13.00
Significant Holders of RxSight, Inc. - Common Stock, $0.001 par value per share (RXST) as of Q2 2025
230 filings reported holding RXST - RxSight, Inc. - Common Stock, $0.001 par value per share as of Q2 2025.
RxSight, Inc. - Common Stock, $0.001 par value per share (RXST) has 171 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37M shares
of 43.8M outstanding shares and own 84.54% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (3.7M shares), BlackRock, Inc. (3.01M shares), VANGUARD GROUP INC (2.28M shares), Artisan Partners Limited Partnership (2.25M shares), D. E. Shaw & Co., Inc. (1.32M shares), DEUTSCHE BANK AG\ (1.23M shares), No Street GP LP (1.2M shares), BROWN CAPITAL MANAGEMENT LLC (1.12M shares), CITADEL ADVISORS LLC (1.03M shares), and MORGAN STANLEY (1M shares).
This table shows the top 171 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.